Patient group direction for Comirnaty® (Pfizer BioNTech)

Document first published:
Page updated:
Topic:
,
Publication type:

This Patient Group Direction (PGD) is for the administration of Comirnaty® COVID-19 mRNA vaccine to individuals in accordance with the national COVID-19 vaccination programme.

Document

Patient group direction for Comirnaty® (Pfizer BioNTech) (PDF version)

Patient group direction for Comirnaty® (Pfizer BioNTech) (PDF version)

  • PDF
  • 403 KB
  • 22 pages

Summary

Published 26 August 2021 and updated 20 September 2021.

Document

Patient group direction for Comirnaty® (Pfizer BioNTech) (Word version)

Patient group direction for Comirnaty® (Pfizer BioNTech) (Word version)

  • Microsoft Word
  • 187 KB
  • 22 pages

Summary

Published 26 August 2021 and updated 20 September 2021.